As of December 22, 2025, AstraZeneca has officially ceased all production and commercial sales of Andexxa in the United States.... Read more
Category: Uncategorized
UK Authorizes Twice-Yearly Injectable for HIV Prevention
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has officially granted marketing authorization for lenacapavir (branded as Yeytuo) for... Read more
A New Chapter in Obesity Management: The Emergence of Oral Weight-Loss Medications
The healthcare industry has reached a significant milestone with the FDA's official approval of the tablet version of semaglutide (Wegovy).... Read more
White House Secures Pricing Accords with Nine Additional Pharmaceutical Giants
In a major step toward implementing the "Most-Favored-Nation" (MFN) pricing policy, the Trump administration has announced individual agreements with nine... Read more
AstraZeneca Inks $2 Billion Deal to Secure Next-Generation Cancer Inhibition Technology
AstraZeneca has officially entered into a global licensing agreement worth up to $2 billion for Jacobio Pharma’s Pan-KRAS inhibitor candidate,... Read more
Korean Bio-Pharma Giant Establishes First Manufacturing Foothold in the United States
Samsung Biologics has secured a $280 million deal to acquire GSK’s manufacturing facilities located in Rockville, Maryland. This strategic move... Read more
Rare Disease Market Shifts as Shionogi Inks $2.5 Billion Asset Acquisition
On December 22, Shionogi revealed a definitive agreement to acquire the amyotrophic lateral sclerosis (ALS) portfolio from Tanabe Pharma. The... Read more
Obesity Treatment Frontier: FDA Approves First-Ever Oral GLP-1 Tablet
The global healthcare market has reached a historic milestone with the FDA's official approval of the oral tablet formulation of... Read more
Unauthorized Clinic in Hue Shutdown Following Severe Regulatory Violations
On December 22, the Hue City Department of Health announced an administrative penalty against the Mb Center (located on To... Read more









